InvestorsHub Logo
Followers 110
Posts 5606
Boards Moderated 0
Alias Born 09/28/2011

Re: None

Thursday, 01/30/2014 3:10:42 PM

Thursday, January 30, 2014 3:10:42 PM

Post# of 75926
Guys, Do Not Make Life Complicated

If Solos performs as expected in terms of sales revenues, developing innovative endoscopy medical devices and applications technology, secure financial capital, and form new strategic partnerships, then the share price would follow naturally.

Numbers do not lie when it comes to sales revenues. Thus, share structure alone would not make or break SNDY. Cheers!